Advertisement
An IL-15 superagonist shows promise
Men with the HSD3B1(1245C) variant metabolize abiraterone differently
Tc9 cells have less intracellular cholesterol than other T cells
Moving radiotherapy beyond a one-size-fits-all approach
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Social and disease- and transplant-related factors
Identifying low and high risk of recurrence
Results based on early data from clinical trial
Early results presented at ASCO 2018
One sequence/combo = longer survival, lower costs
New mRCC medication regimen effective and well tolerated
Advertisement
Advertisement